Contract research
It is a long path from the development of an active pharmaceutical ingredient in the lab to an effective drug – a process that takes several years. Campus companies are often involved in this process on behalf of the pharmaceutical and biotech industry or academic groups.
The company Experimental Pharmacology & Oncology Berlin-Buch (EPO) is a leader in preclinical cancer research in Germany. Worldwide, EPO offers customized and comprehensive service for the preclinical development of novel cancer drugs and is specialized in the development of individualized tumor models.
News innovation
First Joint Career Day Brings Science and Industry Together
The Max Delbrück Center’s Career Day, held in cooperation with the operator of the Berlin-Buch Campus, offered young researchers insights into the working world of startups and biotech companies
more ...Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
more ...Eckert & Ziegler Secures Patient Access to Critical Eye Cancer Treatment with MDR Certification for Ru-106 Eye Applicators
Eckert & Ziegler BEBIG GmbH, subsidiary of Eckert & Ziegler SE with focus on brachytherapy solutions for the treatment of eye tumors and prostate cancer, obtained the MDR certificate for its Ruthenium...
more ...Events Campus
06.06.2026, 17:00
Save the Date! Lange Nacht der Wissenschaften am 6. Juni 2026
Campus Berlin-Buch ist dabei: Von 17 bis 24 Uhr laden dann wieder rund 50 wissenschaftliche und wissenschaftsnahe Einrichtungen in Berlin zu spektakulären Experimenten, spannenden Vorträgen, Wissensch...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...
